RBM17 and cancer: It was found that FaDu cells treated with IC50 concentration of cisplatin could effectively improve the expression level of RBM17 in mRNA, and knockdown of RBM17 in FaDu cells could enhance the sensitivity of cancer cells to cisplatin.